Publisher's MediPoint:Point of Care Diagnostics - Global Analysis and Market Forecasts report provides analysis of the point of care diagnostics space across the 10 major markets of the US, France, Germany, Italy, Spain, the UK, Japan, Brazil, China and India, including annualized market data from 2015 and forecast until 2021.

The POC diagnostics space represents one of the promising and active markets within the in vitro diagnostics (IVD) industry. In 2015, revenue from the POC diagnostics market across the 10MM was $2,133.9m. Sales in the POC diagnostics market are expected to undergo solid growth throughout the forecast period, reaching $2,974.0m in 2021, at a Compound Annual Growth Rate (CAGR) of 5.3%. This growth will occur across the 10 major markets (10MM) of the US, France, Germany, Italy, Spain, the UK, Japan, China, India, and Brazil, will be driven by a number of factors, including the increasing prevalence of lifestyle-related and infectious diseases. Other market drivers include the increasing adoption of cardiac markers in emergency departments, the growing home-testing market, and the potential for POC devices to accelerate patient care decision-making and reduce overall hospital lengths of stay. 

Key questions answered:

-What is the current and future POC diagnostics market outlook in the developed and emerging markets? What trends are affecting the global market?

-What is the competitive landscape and market share of major players in the POC space across different regions?

-What are the key, high growth markets that IVD manufacturers should expand into? Which market segments are growing the fastest?

-What are the unmet needs with the POC tests currently on the market? How will emerging technologies such as molecular POC assays fulfil these unmet needs?

-What are the challenges and barriers that have hindered widespread adoption of POC devices?